Top compounds associated with response to LHFPL3


Feature Type Standardized
Nominal ANOVA
mRNA erismodegib CTRPv2 pan-cancer AAC 0.1 0.004
mRNA methylstat CTRPv2 pan-cancer AAC 0.11 0.005
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.11 0.006
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC -0.085 0.006
mRNA BIRB 0796 GDSC1000 pan-cancer AAC -0.097 0.006
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.1 0.007
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.098 0.008
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.08 0.008
mRNA phenformin GDSC1000 pan-cancer AAC 0.081 0.009
mRNA bendamustine CTRPv2 pan-cancer AAC 0.095 0.009
Download CSV